1. Prowle JR, Westerman M, Bellomo R. Urinary hepcidin: an inverse biomarker of acute kidney injury after cardiopulmonary bypass? Curr Opin Crit Care. 2010; 16:540–544.
Article
2. Scindia Y, Leeds J, Swaminathan S. Iron homeostasis in healthy kidney and its role in acute kidney injury. Semin Nephrol. 2019; 39:76–84.
3. Kim H, Hur M, Lee S, Marino R, Magrini L, Cardelli P, et al. Proenkephalin, neutrophil gelatinase-associated lipocalin, and estimated glomerular filtration rates in patients with sepsis. Ann Lab Med. 2017; 37:388–397.
Article
4. Albert C, Haase M, Albert A, Kropf S, Bellomo R, Westphal S, et al. Urinary biomarkers may complement the cleveland score for prediction of adverse kidney events after cardiac surgery: a pilot study. Ann Lab Med. 2020; 40:131–141.
Article
5. Scindia Y, Wlazlo E, Leeds J, Loi V, Ledesma J, Cechova S, et al. Protective role of hepcidin in polymicrobial sepsis and acute kidney injury. Front Pharmacol. 2019; 10:615.
Article
6. Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Koc-Zorawska E, Matuszkiewicz-Rowinska J, Dobrzycki S. Hepcidin - potential biomarker of contrast-induced acute kidney injury in patients undergoing percutaneous coronary interventions. Adv Med Sci. 2019; 64:211–215.
Article
7. Vela D. Systemic and local hepcidin as emerging and important peptides in renal homeostasis and pathology. Biofactors. 2019; 45:118–134.
Article
8. Choi N, Whitlock R, Klassen J, Zappitelli M, Arora RC, Rigatto C, et al. Early intraoperative iron-binding proteins are associated with acute kidney injury after cardiac surgery. J Thorac Cardiovasc Surg. 2019; 157:287–297.
Article
9. Swaminathan S. Iron homeostasis pathways as therapeutic targets in acute kidney injury. Nephron. 2018; 140:156–159.
Article